CDC advisory panel recommends pediatric COVID-19 Pfizer-BioNTech vaccine for children ages 5 through 11
Today, the Advisory Committee on Immunization Practices (ACIP), a panel of medical and public health experts convened by the federal Centers for Disease Control and Prevention (CDC), voted 14 to 0 to recommend the pediatric Pfizer-BioNTech vaccine for children ages 5 through 11.